Connection
Ha-Neui Kim to Histone Deacetylase Inhibitors
This is a "connection" page, showing publications Ha-Neui Kim has written about Histone Deacetylase Inhibitors.
|
|
Connection Strength |
|
|
|
|
|
1.125 |
|
|
|
-
Kim HN, Lee JH, Jin WJ, Ko S, Jung K, Ha H, Lee ZH. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice. Eur J Pharmacol. 2012 Sep 15; 691(1-3):69-76.
Score: 0.408
-
Kim HN, Lee JH, Bae SC, Ryoo HM, Kim HH, Ha H, Lee ZH. Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription. J Bone Miner Res. 2011 Sep; 26(9):2161-73.
Score: 0.383
-
Kim HN, Ha H, Lee JH, Jung K, Yang D, Woo KM, Lee ZH. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. Eur J Pharmacol. 2009 Nov 25; 623(1-3):22-9.
Score: 0.334